Private Label Kojic Acid & Tranexamic Acid Soap Manufacturer Low MOQ

Most private label manufacturers that specialize in active-ingredient brightening soaps set MOQs between 200 and 1,000 bars for a custom or semi-custom formula run. However, white-label programs — where you apply your branding to a manufacturer's existing TXA or kojic acid syndet bar formula — can start as low as 48 to 100 units. The MOQ is driven by several factors that are worth understanding before you approach suppliers. First, the base format matters enormously. A cold-process or hot-process alkaline soap is incompatible with kojic acid because the high pH destroys the active within days. Any credible manufacturer will use a syndet (synthetic detergent) bar or an acidified melt-and-pour base. Syndet bars are produced on different equipment than traditional soap, and that equipment has a minimum batch size, typically 50–100 kg, which translates to roughly 500–1,000 bars depending on bar weight (80 g is standard for brightening bars). If a manufacturer quotes you a 48-unit MOQ on a syndet brightening bar, ask whether they are running a dedicated batch or piggybacking your order on another client's production run — both are valid, but the latter involves more scheduling risk. Second, packaging drives MOQ as much as production does. Custom-labeled boxes, embossed wrappers, or shrink-sleeve labels each require a minimum print run of 500–2,000 units from most printers. Founders who accept a simpler packaging solution — a stock kraft box with a custom belly band or a sticker label — can stay at 100–200 units economically. This is often the right call for a market-test run before committing to a full branded packaging suite. Third, geography moves the MOQ floor. Southeast Asian manufacturers (Philippines, Thailand, South Korea) frequently accept lower MOQs for brightening bars than US or European manufacturers because brightening soap is a staple product line for them, not a specialty run. Their equipment is already set up and their raw material supply chains for kojic acid and TXA are mature. If you need to stay under 500 units, focus your search on white-label programs with semi-custom label options, Southeast Asian co-manufacturers, and platforms like AJ Cosmo Labs that let you filter specifically by MOQ before making contact. Posting a brief on the AJ Cosmo Labs iOS app allows you to state your MOQ ceiling upfront so only manufacturers who can meet it respond — saving weeks of back-and-forth.

The all-in cost of private labeling a tranexamic acid and kojic acid brightening soap — meaning finished bar, preservative system, packaging, and labeling — typically falls between $2.00 and $8.00 per unit, depending on run size, formula complexity, and sourcing geography. Here is how that range breaks down in practice. At 48–200 units (white-label, stock formula), expect $5–$8 per bar. At this scale, you are paying a significant premium for low-volume production, stock formula access, and often expedited handling. The per-unit packaging cost is also at its highest because print minimums are spread across fewer units. This price point is appropriate for influencer gifting, Etsy launches, or validating demand before a bigger commitment. At 200–500 units (semi-custom), cost drops to approximately $3–$6 per bar. You may pay a one-time formula modification fee of $300–$800 to tweak an existing stock formula — adjusting the kojic acid concentration from 1% to 2%, for example, or adding niacinamide as a supporting brightening active. This fee is amortized into your unit cost if you frame it as a development deposit. At 500–2,000 units (fully custom), per-unit cost typically falls to $2.50–$5. You bear the full cost of formula development ($1,500–$5,000 depending on the lab), stability testing ($500–$2,000 for a 12-week accelerated study), and regulatory documentation. These are fixed costs that become less painful as unit count rises. At 5,000+ units, cost can reach $1.50–$3 per bar at Southeast Asian manufacturers. South Korean and Philippine facilities producing brightening bars at commercial scale often have optimized raw-material procurement for kojic acid and can offer pricing that is difficult to match in the US or Europe at equivalent quality. Beyond manufacturing cost, budget for: third-party stability testing ($500–$2,000), challenge testing if your preservative system needs verification ($400–$1,200), cosmetic labeling compliance review ($200–$800 per SKU), and freight. US Customs duties and import broker fees add $200–$600 to an overseas production run. A realistic first-run budget for a market-ready private label brightening soap at 300–500 units is $5,000–$12,000 all-in, including development, testing, production, packaging, and freight. AJ Cosmo Labs helps founders get competitive quotes from multiple vetted manufacturers through the iOS app so you can compare pricing transparently before committing.

From signed contract to finished product in your warehouse, a private label tranexamic acid and kojic acid brightening soap takes 6 to 16 weeks, depending on whether you start from a stock formula or require full custom development. Understanding each stage and its duration prevents the most common mistake founders make: promising a launch date before they understand the timeline. Weeks 1–2: Brief, supplier selection, and contract. After you post your project and align with a manufacturer, contract negotiation and deposit payment typically take one to two weeks. Do not let this phase drag — manufacturers with low MOQ slots fill quickly. Weeks 2–5 (custom formula) or days 1–7 (stock formula): Formula development. If you are starting from a manufacturer's existing brightening bar formula with minor modifications, this phase is very short — the cosmetic chemist tweaks the kojic acid or TXA concentration, re-checks pH, and prepares a sample batch within one to three weeks. A fully custom formula — new surfactant blend, novel active combination, specific skin feel or lather profile — takes four to eight weeks of lab work before a first sample is ready. Weeks 5–8: Sample review and iteration. You receive the first physical sample and evaluate it for appearance (should be cream to pale ivory — kojic acid oxidizes to yellow/brown if pH is not controlled), fragrance, lather, rinse feel, and on-skin performance. Most projects require one to two rounds of revision, adding two to four weeks. Budget for this — skipping proper sample review is the number one cause of post-launch product returns in the brightening soap category. Weeks 8–12: Stability and safety testing. A 12-week accelerated stability study (40°C/75% RH) runs in parallel with production planning if you have approved your formula. Importantly, you do not need to wait for the full 12-week result before placing a production order in most markets — you can proceed at your own risk with interim 4-week data for an initial run, then complete the study before a major retail rollout. Weeks 10–14: Production and packaging. Once formula is locked and raw materials are in stock, a production run of 200–1,000 bars typically takes one to three weeks on the manufacturing floor, plus one to two weeks for labeling, QC, and packing. Weeks 13–16 (international) or Weeks 11–14 (domestic): Freight and customs. Sea freight from Southeast Asia or Korea adds four to six weeks. Air freight cuts this to one to two weeks at two to four times the cost. US-based production eliminates this phase entirely. Using a platform like AJ Cosmo Labs to identify and brief suppliers in parallel — rather than sequentially — can compress the early stages significantly.

The effective and regulatory-compliant concentration ranges for both actives in a rinse-off soap bar format are narrower than most founders expect, and staying within them is essential for both safety and efficacy. Kojic acid is effective in rinse-off formulas at 0.5% to 2% by weight. The EU Cosmetics Regulation restricts kojic acid to a maximum of 1% in face products and rinse-off body products. If you intend to sell in the EU, cap kojic acid at 1%. In the US, there is currently no specific concentration limit set by FDA for kojic acid as a cosmetic ingredient — many US-market brightening soaps use 1–2%. Going above 2% in a rinse-off product adds cost without proportionally increasing efficacy, because contact time with skin in a bar soap is short (15–60 seconds per use). Transexamic acid (TXA) is used at 2–5% in rinse-off formulations in the clinical and cosmetic literature. Unlike kojic acid, it does not have EU concentration restrictions for cosmetic use, and its stability in a properly pH-controlled syndet base is good. Some high-end private label brightening bars marketed in South Korea use up to 5% TXA, paired with niacinamide and alpha-arbutin as supporting actives. A well-rounded formula for a market-ready TXA + kojic acid soap might look like this in terms of active-ingredient architecture: TXA at 3%, kojic acid at 1% (EU-safe), niacinamide at 2% as a complementary brightener, Vitamin C derivative (ascorbyl glucoside or 3-O-ethyl ascorbic acid) at 1–2% as both a brightener and a kojic acid stabilizer, and EDTA at 0.1% as a chelating agent to protect kojic acid from metal-ion-catalyzed oxidation. The base itself — the syndet surfactant blend — must be formulated to a finished bar pH of 4.5–6.5. This is non-negotiable for kojic acid stability. Ask any potential manufacturer what their target pH is for the finished bar and how they verify it batch-to-batch. A manufacturer who cannot answer this clearly is not equipped to work with these actives. Always pair your formula with a 12-week accelerated stability study to confirm that both actives remain within specification (typically ≥90% of label claim) after simulated shelf-life conditions. AJ Cosmo Labs connects founders with manufacturers and independent cosmetic chemists who can advise on formulation ratios and run stability programs alongside production.

No pre-market FDA approval is required to sell a kojic acid and tranexamic acid soap in the United States, provided the product is positioned and labeled as a cosmetic — not a drug. This is an important distinction because the claims you make on the label and in marketing materials determine whether the FDA classifies your product as a cosmetic (low regulatory burden) or an OTC drug (significant regulatory burden, including pre-market safety and efficacy substantiation). As a cosmetic, your brightening soap must comply with FDA's cosmetic regulations under the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). MoCRA introduced new requirements that are now being phased in: mandatory facility registration for manufacturers (domestic and foreign), product listing with FDA, serious adverse event reporting, and safety substantiation records. These are not pre-market approval requirements, but they are compliance obligations that founders often overlook. The critical claims boundary: you can say a product "brightens skin," "improves the appearance of uneven skin tone," or "reduces the look of dark spots" — these are cosmetic claims about appearance. You cannot say it "treats melasma," "corrects hyperpigmentation," or "inhibits melanin production" — these cross into disease or physiological claims that trigger drug classification. The phrase "clinically proven to reduce dark spots" is a gray area that the FDA has scrutinized; if you use it, have the clinical data to back it up. For ingredient safety, both kojic acid and tranexamic acid are used globally in cosmetics with established safety profiles at standard cosmetic concentrations. There is no FDA-mandated pre-approval for cosmetic ingredients. However, you as the brand owner are legally responsible for ensuring your product is safe before it goes to market. This means your manufacturer should have a safety assessment and stability data on file for the formula. If you sell in California, Proposition 65 is relevant — kojic acid is not currently on the Prop 65 list, but it pays to check current listings before launch since the list is updated periodically. If you plan to export to the EU, registration via the Cosmetic Products Notification Portal (CPNP) and appointment of an EU Responsible Person are required before sale. AJ Cosmo Labs can connect you with manufacturers experienced in multi-market compliance.

Finding a manufacturer who genuinely has experience formulating with tranexamic acid, kojic acid, and syndet bar technology — rather than simply claiming they do — requires a structured vetting process. The brightening soap category has a high rate of unqualified suppliers who rebrand commodity bases with little or no active-ingredient quality control. Start with capability verification. Ask every prospective manufacturer: (1) What syndet base do you use for pH-sensitive active bars? (2) What is your target finished-bar pH, and what is your batch-level QC test for it? (3) Can you share a CoA for your kojic acid raw material from your current supplier? (4) Do you have any existing stability data on a kojic acid or TXA formulation? A capable manufacturer answers all four questions in the first email. An unqualified supplier either deflects or provides answers that reveal they have never actually worked with these actives. Next, assess regulatory capability. If you intend to export, ask whether the facility holds ISO 22716 GMP certification (required for EU market access), whether they can issue a Certificate of Conformity or Manufacturer's Declaration for customs, and whether they have filed cosmetic product notifications in export markets before. For US brands, ask if they are registered with FDA under MoCRA. Third, check references. Ask for the names of two to three current clients whose active-ingredient bar products they manufacture. Reputable manufacturers will provide references or, at minimum, brand names you can verify exist. A manufacturer who refuses this step without a valid confidentiality reason is a red flag. Fourth, protect your IP. If you are funding custom formula development, insist on a written agreement that the formula IP belongs to you upon full payment of development fees. Many manufacturers retain formula ownership by default unless you negotiate otherwise — this is critical if you plan to switch manufacturers at scale or seek acquisition interest later. Finally, use platforms designed for this search rather than cold-searching directories. AJ Cosmo Labs was built specifically to connect indie founders with vetted manufacturers across the cosmetics and personal care space. Downloading the AJ Cosmo Labs iOS app and posting a project brief lets you reach active-ingredient-experienced manufacturers who have already been admin-reviewed for credentials and capability — dramatically reducing the time and risk of the supplier search compared to working from unverified directories or trade show contacts.

Yes, and it is more common than you might expect. The majority of indie founders who launch private label brightening soaps have a marketing, retail, or skincare enthusiast background — not a formulation background. The key is structuring your project correctly so that technical decisions are made by qualified people, even if that person is your manufacturer's in-house cosmetic chemist rather than someone on your team. The most accessible path for a founder with no formulation experience is a white-label or semi-custom program. In a white-label arrangement, the manufacturer has an already-stable, already-tested kojic acid or TXA brightening bar formula. You apply your brand name, logo, and custom packaging to a proven product. The formulation risk is essentially zero because the stability data and safety assessment already exist. This is the fastest and lowest-risk way to get a market-ready product — often 4–8 weeks from contract to finished goods. A semi-custom program lets you specify active-ingredient concentrations, fragrance profile, bar weight, and packaging while the manufacturer handles all formulation science. You pay a moderate development fee ($300–$1,500) for the customization, and the manufacturer's cosmetic chemist does the lab work. You review and approve physical samples before production is confirmed. Fully custom formulation — where you start from a blank formula brief — is not recommended for first-time founders unless you have a specific technical differentiation in mind and the budget for a 4–6 month development process. The additional risk and cost rarely justify the outcome at early commercial stages. Regardless of which path you choose, you should understand three things even without a technical background: (1) your product must be stable (actives must remain effective through shelf life — 18–24 months is standard), (2) your label must be compliant with the FDA requirements for ingredient listing, net weight, and claim language, and (3) you as the brand owner are legally responsible for product safety even if the manufacturer indemnifies you for manufacturing defects. AJ Cosmo Labs is especially useful for founders without formulation experience because the in-app brief format guides you through what information manufacturers actually need to quote and scope your project — you do not need to know the INCI names or syndet chemistry to post a coherent brief. Download the AJ Cosmo Labs app from the App Store, post your brightening soap project, and let experienced manufacturers do the technical heavy lifting.